Morgan Stanley’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.2M Sell
1,568,544
-73,517
-4% -$1.09M ﹤0.01% 2655
2025
Q1
$29.4M Sell
1,642,061
-8,542
-0.5% -$153K ﹤0.01% 2302
2024
Q4
$28.8M Buy
1,650,603
+301,195
+22% +$5.25M ﹤0.01% 2388
2024
Q3
$18.9M Sell
1,349,408
-2,140,254
-61% -$29.9M ﹤0.01% 2854
2024
Q2
$28.7M Sell
3,489,662
-37,958
-1% -$312K ﹤0.01% 2283
2024
Q1
$27.2M Sell
3,527,620
-4,744,960
-57% -$36.6M ﹤0.01% 2356
2023
Q4
$74.4M Buy
8,272,580
+6,032,243
+269% +$54.2M ﹤0.01% 2028
2023
Q3
$20M Buy
2,240,337
+1,441,558
+180% +$12.9M ﹤0.01% 2443
2023
Q2
$12.3M Sell
798,779
-95,091
-11% -$1.46M ﹤0.01% 2970
2023
Q1
$20.1M Buy
893,870
+201,666
+29% +$4.54M ﹤0.01% 2413
2022
Q4
$14.6M Buy
692,204
+319,136
+86% +$6.71M ﹤0.01% 2664
2022
Q3
$9.19M Sell
373,068
-212,705
-36% -$5.24M ﹤0.01% 3072
2022
Q2
$14.2M Buy
585,773
+99,831
+21% +$2.42M ﹤0.01% 2672
2022
Q1
$12.5M Buy
485,942
+174,135
+56% +$4.49M ﹤0.01% 2648
2021
Q4
$9.68M Sell
311,807
-69,128
-18% -$2.15M ﹤0.01% 2977
2021
Q3
$9.24M Buy
380,935
+243,852
+178% +$5.91M ﹤0.01% 2989
2021
Q2
$2M Buy
137,083
+110,710
+420% +$1.62M ﹤0.01% 4631
2021
Q1
$657K Sell
26,373
-33,697
-56% -$839K ﹤0.01% 4996
2020
Q4
$1.64M Buy
60,070
+35,032
+140% +$955K ﹤0.01% 4317
2020
Q3
$462K Sell
25,038
-9,750
-28% -$180K ﹤0.01% 4689
2020
Q2
$710K Buy
34,788
+3,682
+12% +$75.1K ﹤0.01% 4405
2020
Q1
$453K Sell
31,106
-52,500
-63% -$765K ﹤0.01% 4434
2019
Q4
$1.19M Buy
83,606
+42,130
+102% +$598K ﹤0.01% 4418
2019
Q3
$480K Buy
41,476
+20,491
+98% +$237K ﹤0.01% 4699
2019
Q2
$422K Sell
20,985
-11,413
-35% -$230K ﹤0.01% 4694
2019
Q1
$733K Sell
32,398
-170,297
-84% -$3.85M ﹤0.01% 4321
2018
Q4
$4.59M Buy
202,695
+127,658
+170% +$2.89M ﹤0.01% 3006
2018
Q3
$2.16M Sell
75,037
-92,378
-55% -$2.65M ﹤0.01% 3943
2018
Q2
$4.56M Buy
167,415
+4,717
+3% +$129K ﹤0.01% 3244
2018
Q1
$3.64M Buy
162,698
+70,467
+76% +$1.58M ﹤0.01% 3390
2017
Q4
$1.94M Sell
92,231
-32,912
-26% -$693K ﹤0.01% 4060
2017
Q3
$3.12M Buy
125,143
+29,669
+31% +$739K ﹤0.01% 3446
2017
Q2
$1.85M Buy
95,474
+38,145
+67% +$740K ﹤0.01% 3876
2017
Q1
$1.06M Sell
57,329
-89,881
-61% -$1.66M ﹤0.01% 4344
2016
Q4
$2.79M Sell
147,210
-255,006
-63% -$4.83M ﹤0.01% 3612
2016
Q3
$9M Buy
402,216
+356,545
+781% +$7.98M ﹤0.01% 2107
2016
Q2
$813K Buy
45,671
+6,148
+16% +$109K ﹤0.01% 4127
2016
Q1
$539K Buy
39,523
+15,051
+62% +$205K ﹤0.01% 4390
2015
Q4
$472K Sell
24,472
-246,063
-91% -$4.75M ﹤0.01% 4587
2015
Q3
$5.48M Buy
270,535
+48,411
+22% +$981K ﹤0.01% 2575
2015
Q2
$7.36M Buy
222,124
+204,267
+1,144% +$6.77M ﹤0.01% 2420
2015
Q1
$428K Sell
17,857
-5,638
-24% -$135K ﹤0.01% 4767
2014
Q4
$287K Buy
23,495
+22,299
+1,864% +$272K ﹤0.01% 5027
2014
Q3
$11K Sell
1,196
-13,613
-92% -$125K ﹤0.01% 6169
2014
Q2
$174K Buy
14,809
+14,719
+16,354% +$173K ﹤0.01% 5232
2014
Q1
$2K Buy
+90
New +$2K ﹤0.01% 6351